Search

everythinglearnresearchcommunity

for

Search:↓

Tetrathiomolybdate reduces hair growth marker in skin cells by boosting harmful oxygen molecules, but effects can be reversed.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

A 9-year-old girl with a healthy immune system was successfully treated for a severe fungal scalp infection caused by Microsporum audouinii.

Certain alkaloids could help create new coronavirus drugs.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

The compound was successfully made and shows potential for treating prostate cancer.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Some breast cancer chemotherapy can cause permanent hair loss.

Diphencyprone treatment for alopecia areata can cause vitiligo in some patients.

A new treatment using a DNA aptamer can promote hair growth by targeting a specific receptor.

Scientists created tiny particles that release medicine on the skin and in hair, working better at certain pH levels and being safe for skin cells.

Compound 7p shows strong potential as an anticancer agent.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Treatment with dapsone, topical corticosteroids, and antibiotics improved the man's skin conditions.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Cepharanthine and tetrandrine show promise as COVID-19 drugs.

A virus protein can activate a pathway that may lead to abnormal hair follicle development.

Myotonic dystrophy should be considered in patients with hair thinning, and genetic counseling is important.

Combining excimer lamp and tofacitinib gel may help treat hair loss in children.

A mix of specific inhibitors and a growth factor helps keep hair growth cells from losing their properties in the lab.

DRDE-07 shows promise for treating skin diseases due to its favorable properties.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

ZD1839 can cause skin issues like acne and hair changes.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.